SAN FRANCISCO -- The adjuvant combination of pembrolizumab (Keytruda) and belzutifan (Welireg) significantly improved disease ...

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) is one of the top gene therapy stocks to buy according to hedge funds. 4D ...

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative positron emission tomography (PET) radiopharmaceuticals, today announced results ...

The treatment landscape for clear cell renal cell carcinoma (ccRCC) could be due for a shake-up following dual breakthroughs ...

Pluto will complete its first orbit since 1930 in 2178, a historic 248-year space journey that spans generations of humans.

Microsimulation studies on alcohol pricing policy,1 represent an important advance in modelling the effects of pricing-based interventions.2 However, a real-world development with the potential to ...

Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna ...

While the FDA has flip-flopped on whether to review Moderna’s combination influenza and COVID-19 vaccine, it’s full speed ...

February 4, 2026) - VRC Medical Services, a specialty pharmaceutical distribution company supporting clinical research, announced recent expansion of its comparator sourcing infrastructure designed to ...

WPP’s restructuring under Cindy Rose signals the end of the legacy agency brand era, as AI, consolidation, and ...

SHANGHAI, Feb 26 (Reuters) - Jiuyuan Genetic Biopharmaceutical has applied for approval to sell its experimental biosimilar version of Novo Nordisk's blockbuster weight-loss drug Wegovy in China, the ...

Novo Nordisk's executives express strong optimism about Cagrisema, highlighting its superior weight loss efficacy compared to current market products. Despite noting an abnormality with a comparator ...